Abstract
Blocking glutamatergic transmission at the N-methyl-d-aspartate (NMDA) receptor complex with MK-801 (0.15–0.5 mg/kg, IP) was found to induce a robust, dose-dependent increase in locomotor activity. This behavioural activation was similar in intensity to that observed afterd-amphetamine (1 mg/kg, SC). The locomotor stimulation induced by MK-801 at 0.3 mg/kg was significantly inhibited by the D2 dopamine receptor antagonist raclopride (0.1–0.3 mg/kg, SC) and by the D1 receptor antagonist SCH 23390 (0.04 mg/kg, SC). The locomotor activity induced by a higher dose of MK-801 (0.5 mg/kg) was reduced by higher doses of raclopride or SCH 23390 administered alone (0.3 and 0.08 mg/kg, respectively), and was inhibited by simultaneous administration of ineffective doses. Raclopride significantly reducedd-amphetamine-induced locomotor activity at a dose (0.2 mg/kg) that also blocked the effects of a low dose of MK-801. In contrast, SCH 23390 blocked the effects ofd-amphetamine at a dose (i.e. 0.01 mg/kg) lower than that needed to block MK-801. These results suggest that the dopaminergic system may in part mediate the locomotor effects induced by the NMDA antagonist, MK-801, in rats. However, the locomotor activity induced by MK-801 appears to be less sensitive to dopaminergic receptor blockade than that induced byd-amphetamine, suggesting that the underlying mechanisms, although similar, are not identical.
Similar content being viewed by others
References
Albin RL, Makowiec RL, Hollingsworth ZR, Dure IV LS, Penney JB, Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic and in situ hybridation techniques. Neuroscience 46:35–48
Amalric M, Ouagazzal A, Nieoullon A (1991) Glutamate-dopamine functional interaction within the striatum and the nucleus accumbens. 21th Soc for Neurosciences, New Orleans, S 198–20
Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221–226
Clineschmidt BV, Martin GE, Bunting PR, Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev Res 2:135–145
Costall B, Naylor RW, Olley J (1982) Stereotypy and anti-cataleptic action of amphetamine after intracerebral injection. Eur J Pharmacol 18:83–94
Dall'Olio R, Gandolfi O, Montarano N (1992) Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonist in the rat. Pychopharmacology 107:591–594
Donzanti BA, Uretsky NJ (1984) Antagonism of the hypermotility response induced by excitatory amino acids in the rats nucleus accumbens. Naunyn-Schmidedberg's Arch Pharmacol 325:1–7
Dubois A, Savasta M, Curet O, Scatton B (1986) Autoradiographic distribution of the D1 agonist3(H) SKF 38393 in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 19:125–137
Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42:1–11
Halpain S, Girault JA, Greengard P (1990) Activation of NMDA receptor induces dephosphorylation of DARPP-32 in rats striatal slices. Nature 343:369–371
Hoffman DC (1992) Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J Neural Transm 89:1–10
Imperato A, Scrocco MG, Bacchi S, Angelucci L (1990) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur J Pharmacol 187:555–556
Johnson SW, Palmer MR, Freedman R (1983) Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology 22:843–851
Kannari K, Markstein R (1991) Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice. J Neural Transm 84:211–220
Klitenick MA, Deutch AY, Churchill L, Kalivas P (1992) Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience 50:371–386
Koek W, Woods JH, Ornstein P (1987) A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats. Psychopharmacology 91:297–304
Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969–974
Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155–234
Liljequist S, Ossowska K, Grabowska-Andén M, Andén N (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55–61
Löscher W, Annies R, Hönack D (1991) The N-methyl-d-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonine metabolism in several brain regions of rats. Neurosci Lett 198:191–194
Mansour A, Meador-Woodruff JH, Zhou Q, Civelli O, Akil H, Watson SJ (1992) A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959–971
Moghaddam B, Gruen RJ (1991) Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res 544:329–330
Nieoullon A, Kerkerian-Le Goff (1992) Cellular interactions in the striatum involving neuronal systems using “classical” neurotransmitters: possible functional implications. Mov Disord 7:311–325
Nieoullon A, Kerkerian L, Dusticier N (1983) Presynaptic dopaminergic control of high affinity glutamate uptake in the striatum. Neurosci Lett 43:191–196
Raffa RB, Ortegon ME, Robisch DM, Martin GE (1989) In vivo demonstration of the enhancement of MK-801 byl-glutamate. Life Sci 44:1593–1599
Richter CP, Hawkes CD (1939) Increased spontaneous activity and food intake produced in rats by removal prefrontal poles of the brain. J Neurol Psychiatry 2:231–242
Scatton B, Worms P, Llyod KG, Bartholini G (1982) Cortical modulation of striatal function. Brain Res 232:331–343.
Schmidt WJ (1986) Intrastriatal injection of DL-2 amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90:123–130
Schmidt WJ, Bury D (1988) Behavioural effects of N-methyl-d-aspartate in the anterodorsal striatum of the rat. Life Sci 43:545–549
Sharp T, Zetterström T, Ljunberg T, Ungerstedt U (1987) A direct comparison of amphetamine-induced behaviours and regional brain release in the rat using intracerebral dialysis. Brain Res 401:322–330
Statton LM, Solomon (1984) Microanalysis ofd-amphetamine into the nucleus accumbens and caudate putamen. Physiol Psychol 12:159–162
Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169–179
Tiedtke PI, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm 81:173–182
Tricklebank MK, Singh L, Oles RJ, Preston C, Iversen SD (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167:127–135
Vives F, Mogenson GF (1986) Electrophysiological study of the effects of D1 and D2 dopamine antagonists on the interaction of converging inputs from the sensory-motor cortex and substantia nigra neurons in the rat. Neuroscience 17:349–359
Welzl H, Bertz S, Batting K (1991) The effects of the non-competitive NMDA receptor antagonist MK-801 on DRL performance in rats. Psychobiology 19:211–216
Whishaw IQ, Auer RN (1989) Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat. Psychopharmacology 98:500–507
Wong EHF, Knight AR, Woodruff GN (1988) (3H) MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rats brain membranes. J Neurochem 50:274–281
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ouagazzal, A., Nieoullon, A. & Amalric, M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology 111, 427–434 (1993). https://doi.org/10.1007/BF02253532
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02253532